J, L., Y, M., C, S., Q, C., S, C., X, Z., & C, Z. (2026). Regional citrate versus systemic heparin anticoagulation in continuous renal replacement therapy for sepsis-associated acute kidney injury: A retrospective cohort study of short-term outcomes. The Journal of international medical research, 54(6), 3000605261464273. https://doi.org/10.1177/03000605261464273
Chicago Style (17th ed.) CitationJ, Lan, Mao Y, Shi C, Chen Q, Cai S, Zhang X, and Zheng C. "Regional Citrate Versus Systemic Heparin Anticoagulation in Continuous Renal Replacement Therapy for Sepsis-associated Acute Kidney Injury: A Retrospective Cohort Study of Short-term Outcomes." The Journal of International Medical Research 54, no. 6 (2026): 3000605261464273. https://doi.org/10.1177/03000605261464273.
MLA (9th ed.) CitationJ, Lan, et al. "Regional Citrate Versus Systemic Heparin Anticoagulation in Continuous Renal Replacement Therapy for Sepsis-associated Acute Kidney Injury: A Retrospective Cohort Study of Short-term Outcomes." The Journal of International Medical Research, vol. 54, no. 6, 2026, p. 3000605261464273, https://doi.org/10.1177/03000605261464273.